EGFR and non-small cell lung carcinoma: In non-small cell lung cancer, oncogenic alterations in the epidermal growth factor receptor (EGFR) increase cellular sensitivity to ferroptosis, due to mitogen-activated protein kinase (MAPK) signaling-mediated NADPH oxidase 4 (NOX4) activation (Poursaitidis et al., 2017).